Quantitative magnetization transfer imaging in Alzheimer disease

Area of Science:

• Neuroimaging
• Biomarkers
• Alzheimer's Disease Research

Background:

• Alzheimer disease (AD) is characterized by neurodegeneration.
• Established atrophy parameters are used to track disease progression.
• Novel imaging techniques are needed for early and accurate diagnosis.

Purpose of the Study:

• To prospectively measure magnetization transfer (MT) parameters in patients with Alzheimer disease (AD).
• To compare MT parameters with established atrophy measures.
• To evaluate the potential of MT parameters as biomarkers for AD.

Main Methods:

• Volumetric T1-weighted MRI and MT imaging were performed on 14 AD patients and 14 controls.
• Whole-brain and hippocampal volumes were assessed.
• Four fundamental MT parameters were derived from the hippocampal region using a two-pool model.

Main Results:

• Patients with AD showed significantly reduced whole-brain and hippocampal volumes.
• Two MT parameters, 1/(RAT2A) and f*b, were significantly reduced in the hippocampus of AD patients.
• Hippocampal volume and MT parameters correlated with Mini-Mental State Examination (MMSE) scores.

Conclusions:

• Certain MT parameters may serve as valuable biomarkers for Alzheimer disease.
• MT imaging offers a potential tool for assessing AD-related brain changes.
• Further research can explore the clinical utility of these MT biomarkers.